• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Champions Oncology, Inc. - Common Stock (NQ:CSBR)

    6.930 +0.380 (+5.80%)
    Streaming Delayed Price Updated: 12:02 PM EST, Dec 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,181
    Open 6.740
    Bid (Size) 6.650 (300)
    Ask (Size) 7.180 (300)
    Prev. Close 6.550
    Today's Range 6.550 - 6.930
    52wk Range 5.592 - 11.99
    Shares Outstanding 13,415,066
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Champions Oncology Inc (NASDAQ:CSBR) Beats Revenue Estimates and Returns to Profitability in Q2 ↗
    Champions Oncology beats Q2 revenue estimates, returns to profit with record service revenue and expanding margins. 
    Via Chartmill
    News headline image
    Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
    Via ACCESS Newswire

    Performance

    YTD
    -15.5%
    -15.5%
    1 Month
    +15.5%
    +15.5%
    3 Month
    +7.0%
    +7.0%
    6 Month
    -3.9%
    -3.9%
    1 Year
    -19.6%
    -19.6%

    More News

    Read More
    News headline image
    Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
    Via ACCESS Newswire
    News headline image
    CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
    Via ACCESS Newswire
    News headline image
    Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss ↗
    Via Chartmill
    News headline image
    Insights Ahead: Champions Oncology's Quarterly Earnings ↗
    Via Benzinga
    News headline image
    Champions Oncology Reports Record Annual Revenue of $57 Million
    Via ACCESS Newswire
    News headline image
    Earnings Scheduled For July 23, 2025 ↗
    Via Benzinga
    News headline image
    Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
    Via ACCESS Newswire
    News headline image
    Earnings Scheduled For September 15, 2025 ↗
    Via Benzinga
    News headline image
    Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
    Via ACCESS Newswire
    News headline image
    4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week ↗
    Via Benzinga
    News headline image
    Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
    Via ACCESS Newswire
    News headline image
    Recap: Champions Oncology Q2 Earnings ↗
    Via Benzinga
    News headline image
    Champions Oncology Announces Appointment of New CEO
    Via ACCESS Newswire
    News headline image
    Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
    Via ACCESS Newswire
    News headline image
    Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
    Via ACCESS Newswire
    News headline image
    Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine
    Via ACCESS Newswire
    News headline image
    Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million
    Via ACCESS Newswire
    News headline image
    Earnings Scheduled For March 11, 2025 ↗
    Via Benzinga
    News headline image
    Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025
    Via ACCESS Newswire
    News headline image
    Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
    Via ACCESS Newswire
    News headline image
    Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
    Via ACCESSWIRE

    Frequently Asked Questions

    Is Champions Oncology, Inc. - Common Stock publicly traded?
    Yes, Champions Oncology, Inc. - Common Stock is publicly traded.
    What exchange does Champions Oncology, Inc. - Common Stock trade on?
    Champions Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Champions Oncology, Inc. - Common Stock?
    The ticker symbol for Champions Oncology, Inc. - Common Stock is CSBR on the Nasdaq Stock Market
    What is the current price of Champions Oncology, Inc. - Common Stock?
    The current price of Champions Oncology, Inc. - Common Stock is 6.930
    When was Champions Oncology, Inc. - Common Stock last traded?
    The last trade of Champions Oncology, Inc. - Common Stock was at 12/31/25 12:02 PM ET
    What is the market capitalization of Champions Oncology, Inc. - Common Stock?
    The market capitalization of Champions Oncology, Inc. - Common Stock is 92.97M
    How many shares of Champions Oncology, Inc. - Common Stock are outstanding?
    Champions Oncology, Inc. - Common Stock has 93M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.